We are live on ! Find out more
BFEC

Benjamin F. Edwards & Company Portfolio holdings

AUM $5.69B
1-Year Est. Return 15.37%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+15.37%
3 Year Est. Return
+19.73%
5 Year Est. Return
+83.07%
10 Year Est. Return
+162.03%
AUM
$611M
AUM Growth
+$45.2M
Cap. Flow
+$40M
Cap. Flow %
6.55%
Top 10 Hldgs %
17.79%
Holding
1,308
New
176
Increased
448
Reduced
218
Closed
58
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
151
Accenture
ACN
$115B
$964K 0.16%
8,226
+2,440
+42% +$290K
LMBS icon
152
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.42B
$950K 0.16%
18,204
+11,757
+182% +$617K
FXU icon
153
First Trust Utilities AlphaDEX Fund
FXU
$803M
$945K 0.15%
35,339
-945
-3% -$24.5K
AMX icon
154
America Movil
AMX
$70.4B
$920K 0.15%
73,200
COP icon
155
ConocoPhillips
COP
$156B
$914K 0.15%
18,221
-1,607
-8% -$74.1K
BCX icon
156
BlackRock Resources & Commodities Strategy Trust
BCX
$996M
$907K 0.15%
109,713
+256
+0.2% +$2.07K
JKHY icon
157
Jack Henry & Associates
JKHY
$12.1B
$905K 0.15%
10,190
+3,237
+47% +$276K
SO icon
158
Southern Company
SO
$102B
$894K 0.15%
18,176
+555
+3% +$27.3K
VUG icon
159
Vanguard Morningstar Growth ETF
VUG
$229B
$884K 0.14%
47,604
-11,574
-20% -$214K
FBGX
160
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$877K 0.14%
6,331
BR icon
161
Broadridge
BR
$20.9B
$876K 0.14%
13,220
+4,510
+52% +$293K
BRK.B icon
162
Berkshire Hathaway Class B
BRK.B
$1.08T
$871K 0.14%
5,342
+693
+15% +$107K
XBI icon
163
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$862K 0.14%
14,555
+7,878
+118% +$486K
OA
164
DELISTED
Orbital ATK, Inc.
OA
$847K 0.14%
9,656
+5,094
+112% +$415K
BDX icon
165
Becton Dickinson
BDX
$51.2B
$838K 0.14%
5,187
-62
-1% -$10.3K
BA icon
166
Boeing
BA
$166B
$833K 0.14%
5,349
+3,241
+154% +$473K
GSK icon
167
GSK
GSK
$101B
$829K 0.14%
17,214
+936
+6% +$46.2K
VFC icon
168
VF Corp
VFC
$5.36B
$819K 0.13%
16,302
+1,890
+13% +$98K
BMY icon
169
Bristol-Myers Squibb
BMY
$137B
$817K 0.13%
13,980
+3,564
+34% +$195K
ADI icon
170
Analog Devices
ADI
$181B
$814K 0.13%
11,214
+722
+7% +$49.1K
ABBV icon
171
AbbVie
ABBV
$456B
$806K 0.13%
12,873
+3,988
+45% +$243K
ABT icon
172
Abbott
ABT
$193B
$801K 0.13%
20,848
+9,233
+79% +$366K
CL icon
173
Colgate-Palmolive
CL
$72.5B
$788K 0.13%
12,044
+705
+6% +$48.3K
NZF icon
174
Nuveen Municipal Credit Income Fund
NZF
$2.4B
$784K 0.13%
55,422
+5,390
+11% +$77.7K
GATX icon
175
GATX Corp
GATX
$6.3B
$776K 0.13%
12,600
+3,210
+34% +$166K

Similar funds

Benjamin F. Edwards & Company's Q4 2016 Portfolio in Review

As of Q4 2016, Benjamin F. Edwards & Company held 1,308 positions worth $611M, up 8% from $566M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Benjamin F. Edwards & Company deployed $40M of net new capital in Q4 2016, opening 176 new positions and adding to 448 existing holdings. Its largest new stake was First Trust NASDAQ-100 Technology Index Fund: 49,529 shares worth $2.61M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 58% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Growth ETF, an estimated $4.79M trimmed.

  • Benjamin F. Edwards & Company's largest Q4 2016 buy was First Trust NASDAQ-100 Technology Index Fund: 49,529 shares worth $2.61M.
  • Benjamin F. Edwards & Company added most to Vanguard FTSE Emerging Markets ETF in Q4 2016, an estimated $8.41M increase.
  • Benjamin F. Edwards & Company's biggest Q4 2016 reduction was Vanguard Morningstar Small-Cap Growth ETF, cutting an estimated $4.79M.
  • Benjamin F. Edwards & Company fully exited ProShares Short 20+ Year Treasury ETF in Q4 2016, selling an estimated $1.04M.
  • Benjamin F. Edwards & Company's ten largest holdings make up 18% of its $611M portfolio in Q4 2016.
  • Benjamin F. Edwards & Company opened 176 new positions and closed 58 in Q4 2016.
  • Benjamin F. Edwards & Company's portfolio value rose 8% quarter-over-quarter to $611M.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2016, filed 18 Jan 2017.